News for Healthier Living

Delaying Pegfilgrastim Administration Reduces Bone Pain in Patients with Breast Cancer Undergoing Chemotherapy

A randomized clinical trial found that administering pegfilgrastim, a drug that treats neutropenia caused by cancer medicines, 72 hours after chemotherapy sharply reduces pegfilgrastim-induced bone pain (PIBP) in breast cancer patients without increasing the risk of dangerous infections.

March 23, 2026


March 28 2026

March 27 2026

March 26 2026

March 25 2026

March 24 2026

March 23 2026

March 22 2026

March 21 2026

March 20 2026

March 19 2026

March 18 2026

March 17 2026

March 16 2026

March 15 2026